Summary:
- This article discusses a new study that has identified a potential therapeutic target for treating Alzheimer's disease.
- The researchers found that a protein called TREM2 plays a crucial role in the brain's immune response to the buildup of amyloid-beta, a hallmark of Alzheimer's disease.
- By targeting TREM2, the researchers believe they may be able to develop new treatments that could slow or even prevent the progression of Alzheimer's disease.